Ketamine Completed Phase 3 Trials for Delirium Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT01690988The Prevention of Delirium and Complications Associated With Surgical Treatments Multi Center Clinical Trial